/

For Powder, reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

本产品仅用作科学研究！

Anti-SIRPa / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

The purity of Anti-SIRPa / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA) is more than 95%, determined by SEC-HPLC.

Immobilized human SIRPα V1 FC at 4 ug/mL can bind Hospital for Sick Children patent anti-SIRPA, EC50=0.007292 ug/mL.

Hospital for Sick Children patent anti-SIRPA FACS Blocking was evaluated using human CCRF-CEM cells. The IC50 was approximately 3.289 ug/ml. nM.

-80°C for 2 years under sterile conditions；-20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.